静脉动脉-体外膜肺氧合在肺动脉高压治疗中的研究进展  

Venoarterial Extracorporeal Membrane Oxygenation in Treatment of Pulmonary Hypertension

作　　者：刘欢 周金花[2] LIU Huan;ZHOU Jinhua(Department of Emergency Internal Medicine,Jining No.1 People’s Hospital,Jining 272000,Shandong,China;Department of Pulmonary and Critical Care Medicine,Jining No.1 People’s Hospital,Jining 272000,Shandong,China)

机构地区：[1]济宁市第一人民医院急诊内科,山东济宁272000 [2]济宁市第一人民医院呼吸与危重症医学科,山东济宁272000

出　　处：《心血管病学进展》2024年第11期1016-1020,共5页Advances in Cardiovascular Diseases

摘　　要：静脉动脉-体外膜肺氧合(VA-ECMO)是一项用于治疗严重心肺功能障碍患者的体外循环技术。它通过模拟心肺功能,提升血氧水平,减轻心脏负荷,在处理肺动脉高压方面发挥着重要作用。作为一种临时生命支持手段,可对心肺功能衰竭的肺动脉高压患者进行短期治疗,延长治疗时间,推动病情好转,为肺血管修复和重建提供契机。VA-ECMO在不同类型的肺动脉高压中均扮演着重要角色,有助于挽救患者生命,减少永久性心肺功能损伤。现对VA-ECMO在肺动脉高压治疗方面的研究进展进行综述。Venoarterial extracorporeal membrane oxygenation(VA-ECMO)is an extracorporeal circulation technique used to treat patients with severe cardiopulmonary dysfunction.It simulates the functions of the heart and lungs,increases blood oxygen levels,reduces cardiac workload,and plays an important role in managing pulmonary hypertension.As a temporary life support measure,it provides short-term treatment for pulmonary hypertension in patients with cardiopulmonary failure,prolongs treatment time,promotes improvement in the condition,and provides an opportunity for pulmonary vascular repair and reconstruction.VA-ECMO plays a significant role in various types of pulmonary hypertension,helping to save patients’lives and reduce permanent cardiopulmonary functional damage.This article reviews the research progress of VA-ECMO in the treatment of pulmonary hypertension.

关 键 词：静脉动脉-体外膜肺氧合 肺动脉高压 体外循环技术 

分 类 号：R544.1[医药卫生—心血管疾病]